Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

Z He, JL Guo, JD McBride, S Narasimhan, H Kim… - Nature medicine, 2018 - nature.com
Z He, JL Guo, JD McBride, S Narasimhan, H Kim, L Changolkar, B Zhang, RJ Gathagan
Nature medicine, 2018nature.com
Alzheimer's disease (AD) is characterized by extracellular amyloid-β (Aβ) plaques and
intracellular tau inclusions. However, the exact mechanistic link between these two AD
lesions remains enigmatic. Through injection of human AD-brain-derived pathological tau
(AD-tau) into Aβ plaque–bearing mouse models that do not overexpress tau, we
recapitulated the formation of three major types of AD-relevant tau pathologies: tau
aggregates in dystrophic neurites surrounding Aβ plaques (NP tau), AD-like neurofibrillary …
Abstract
Alzheimer's disease (AD) is characterized by extracellular amyloid-β (Aβ) plaques and intracellular tau inclusions. However, the exact mechanistic link between these two AD lesions remains enigmatic. Through injection of human AD-brain-derived pathological tau (AD-tau) into Aβ plaque–bearing mouse models that do not overexpress tau, we recapitulated the formation of three major types of AD-relevant tau pathologies: tau aggregates in dystrophic neurites surrounding Aβ plaques (NP tau), AD-like neurofibrillary tangles (NFTs) and neuropil threads (NTs). These distinct tau pathologies have different temporal onsets and functional consequences on neural activity and behavior. Notably, we found that Aβ plaques created a unique environment that facilitated the rapid amplification of proteopathic AD-tau seeds into large tau aggregates, initially appearing as NP tau, which was followed by the formation and spread of NFTs and NTs, likely through secondary seeding events. Our study provides insights into a new multistep mechanism underlying Aβ plaque–associated tau pathogenesis.
nature.com